Incidence and consequences of chyle leak after pancreatectomy for pancreatic cancer.
[BACKGROUND] Chyle leak after pancreatic surgery is linked to malnutrition, but its impact on oncological outcomes is unclear.
- 95% CI 0.57-1.16
APA
Ishida J, Franklin O, et al. (2026). Incidence and consequences of chyle leak after pancreatectomy for pancreatic cancer.. HPB : the official journal of the International Hepato Pancreato Biliary Association, 28(3), 369-378. https://doi.org/10.1016/j.hpb.2025.10.004
MLA
Ishida J, et al.. "Incidence and consequences of chyle leak after pancreatectomy for pancreatic cancer.." HPB : the official journal of the International Hepato Pancreato Biliary Association, vol. 28, no. 3, 2026, pp. 369-378.
PMID
41771619
Abstract
[BACKGROUND] Chyle leak after pancreatic surgery is linked to malnutrition, but its impact on oncological outcomes is unclear. This study assessed if postoperative clinically relevant chyle leak (CR-chyle leak) affects adjuvant chemotherapy receipt rates and overall survival (OS) in pancreatic cancer patients.
[METHODS] Patients who underwent resection for localized pancreatic ductal adenocarcinoma at the University of Colorado Hospital (2015-2023) were included. Year of surgery was divided in two time periods based on changes in dissection techniques, increased neoadjuvant therapies, and more surgeries for advanced disease in 2019. Risk factors for CR-chyle leak (grade B-C) and their relation to OS and adjuvant chemotherapy were analyzed using logistic and Cox regression models.
[RESULTS] Among 487 patients, 93 (19.5 %) developed CR-chyle leak. Patients with CR-chyle leak more often had borderline/locally advanced disease, neoadjuvant chemotherapy, vascular resections, longer surgeries, and operated in 2019-2023. There were no differences in hospital stay (median 10 vs 10 days), adjuvant chemotherapy rates (70.5 % vs 70.2 %, p = 0.917), or median OS (28.5 vs 29.9 months, p = 0.477). CR-chyle leak was not associated with OS (HR 0.81; 95 % CI: 0.57-1.16) in the adjusted model.
[CONCLUSION] CR-chyle leak is common after pancreatic cancer surgery but does not negatively impact oncological outcomes.
[METHODS] Patients who underwent resection for localized pancreatic ductal adenocarcinoma at the University of Colorado Hospital (2015-2023) were included. Year of surgery was divided in two time periods based on changes in dissection techniques, increased neoadjuvant therapies, and more surgeries for advanced disease in 2019. Risk factors for CR-chyle leak (grade B-C) and their relation to OS and adjuvant chemotherapy were analyzed using logistic and Cox regression models.
[RESULTS] Among 487 patients, 93 (19.5 %) developed CR-chyle leak. Patients with CR-chyle leak more often had borderline/locally advanced disease, neoadjuvant chemotherapy, vascular resections, longer surgeries, and operated in 2019-2023. There were no differences in hospital stay (median 10 vs 10 days), adjuvant chemotherapy rates (70.5 % vs 70.2 %, p = 0.917), or median OS (28.5 vs 29.9 months, p = 0.477). CR-chyle leak was not associated with OS (HR 0.81; 95 % CI: 0.57-1.16) in the adjusted model.
[CONCLUSION] CR-chyle leak is common after pancreatic cancer surgery but does not negatively impact oncological outcomes.
MeSH Terms
Humans; Pancreatectomy; Pancreatic Neoplasms; Male; Female; Middle Aged; Aged; Incidence; Risk Factors; Chemotherapy, Adjuvant; Retrospective Studies; Carcinoma, Pancreatic Ductal; Chyle; Anastomotic Leak; Time Factors; Neoadjuvant Therapy
같은 제1저자의 인용 많은 논문 (4)
- Intraoperative frozen section analysis of the portal or superior mesenteric vein transection margin in pancreatectomy with venous resection for pancreatic cancer.
- ASO Visual Abstract: Short- and Long-Term Outcomes after Pancreatectomy for Pancreatic Cancer in Patients with Prior Esophagectomy for Esophageal Cancer.
- Short- and Long-Term Outcomes after Pancreatectomy for Pancreatic Cancer in Patients with Prior Esophagectomy for Esophageal Cancer.
- Learning Curve Effect in Reducing Local Recurrence Rate After Resection of Pancreatic Cancer With Arterial Abutment: A Single-Center Retrospective Study.